Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma. - Campbell KM; Amouzgar M; Pfeiffer SM; Howes TR; Medina E; Travers M; Steiner G; Weber JS; Wolchok JD; Larkin J; Hodi FS; Boffo S; et al. (Cancer cell, 2023)